Visual control and registration of body image to determine risk by abdominal perimeter and treatment evolution response. Contents: 1. Raw-Data Motivation 2. Data-Key 3. EvolutionChart Clin
Background: Ustekinumab is used off-label in pediatric Crohn’s disease refractory to anti-tumor necrosis factor. Data on optimal dosing, target trough levels, and potential benefit of therapeutic drug